Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Anterior Segment > Anterior chamber IOLs tied to higher graft failure risk after DSEK in eyes without glaucoma
  • Anterior Segment

Anterior chamber IOLs tied to higher graft failure risk after DSEK in eyes without glaucoma

Ophthalmology 360

Key Takeaways

  1. Visual acuity gains and most postoperative complication rates were similar between ACIOL and PCIOL groups.
  2. Anterior chamber IOLs were associated with a higher risk of secondary graft failure in eyes without glaucoma.
  3. No increased secondary graft failure risk was seen in eyes with prior glaucoma surgery

Anterior chamber intraocular lenses were linked to a higher risk of secondary graft failure after Descemet stripping endothelial keratoplasty (DSEK) in eyes without glaucoma, according to a study.

The study included 132 DSEK procedures in eyes with anterior chamber intraocular lenses (ACIOLs) and 608 procedures in eyes with posterior chamber intraocular lenses (PCIOLs).

Visual acuity improvement and rates of primary graft failure, graft dislocation, endothelial rejection, and postoperative intraocular pressure elevation were similar between groups. However, glaucoma surgery was performed more often in the ACIOL group than in the PCIOL group.

Secondary graft failure occurred at similar rates overall in the ACIOL and PCIOL groups, but outcomes differed based on glaucoma status. In eyes without glaucoma, the presence of an ACIOL significantly increased the risk of secondary graft failure, and a trend toward increased risk was seen in eyes with medically treated glaucoma. No increased risk was observed in eyes with prior glaucoma surgery. Prior graft failure and endothelial rejection were also associated with a greater risk of secondary graft failure.

The investigators concluded that intraocular lens exchange should be considered before DSEK in eyes with an ACIOL if the eye has not undergone prior glaucoma surgery.

Reference
Ghaffari R, Kong AW, Duong HNV, et al. Outcomes of Descemet Stripping Endothelial Keratoplasty in Eyes With Anterior Chamber Intraocular Lenses. Cornea. 2026;doi: 10.1097/ICO.0000000000004168. Epub ahead of print. PMID: 42385227.

Share

Related Content

  • Cataract

IOL exchange shows highest success for dissatisfaction after presbyopia-correcting lens surgery

  • Cataract

Head-to-head study highlights differences between EDoF intraocular lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

  • Conference Roundup

Real-world study shows TECNIS PureSee IOL offers low levels of bothersome visual symptoms, indicating high-quality vision

  • Conference Roundup

Extended depth of focus IOLs are an option for IOL exchange in patients intolerant of multifocal IOLs

  • Conference Roundup

TECNIS PureSee IOL induces quality vision, contrast, and uncorrected vision

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon